516 research outputs found

    Monovalent Ion Condensation at the Electrified Liquid/Liquid Interface

    Full text link
    X-ray reflectivity studies demonstrate the condensation of a monovalent ion at the electrified interface between electrolyte solutions of water and 1,2-dichloroethane. Predictions of the ion distributions by standard Poisson-Boltzmann (Gouy-Chapman) theory are inconsistent with these data at higher applied interfacial electric potentials. Calculations from a Poisson-Boltzmann equation that incorporates a non-monotonic ion-specific potential of mean force are in good agreement with the data.Comment: 4 pages, 4 figure

    Vaporization and Layering of Alkanols at the Oil/Water Interface

    Full text link
    This study of adsorption of normal alkanols at the oil/water interface with x-ray reflectivity and tensiometry demonstrates that the liquid to gas monolayer phase transition at the hexane/water interface is thermodynamically favorable only for long-chain alkanols. As the alkanol chain length is decreased, the change in excess interfacial entropy per area decreases to zero. Systems with small values of excess interfacial entropy form multi-molecular layers at the interface instead of the monolayer formed by systems with much larger excess interfacial entropy. Substitution of n-hexane by n-hexadecane significantly alters the interfacial structure for a given alkanol surfactant, but this substitution does not change fundamentally the phase transition behavior of the monolayers. These data show that the critical alkanol carbon number, at which the change in excess interfacial entropy per area decreases to zero, is approximately six carbons larger than the number of carbons in the alkane solvent molecules.Comment: 27 pages, 10 figures, to be published in J. Phys. Cond. Ma

    The Medical Research Council Myeloma IX trial: the impact on treatment paradigms*

    Get PDF
    Osteolytic bone disease is a hallmark of symptomatic multiple myeloma. Bisphosphonates have been the mainstay of treatment to preserve skeletal integrity and prevent skeletal-related events in patients with myeloma-related bone disease. Recently, the MRC Myeloma IX trial demonstrated for the first time improved survival and delayed disease progression with the use of an intravenous amino-bisphosphonate, zoledronic acid, vs. an oral agent, clodronate, with intensive and non-intensive anti-myeloma treatment regimens in patients with newly diagnosed multiple myeloma. These results validate a large body of preclinical, translational and other clinical data suggesting anti-myeloma effects of amino-bisphosphonates. In addition, this trial also provided the first head-to-head evidence for superiority of one bisphosphonate over another (zoledronic acid vs. clodronate) for reducing skeletal morbidity in patients with multiple myeloma, as well as a prospective comparison of toxicities. Despite the use of non-bortezomib containing anti-myeloma treatment regimens in the MRC Myeloma IX trial, these results are encouraging and provide an impetus to continue to evaluate current treatment guidelines for myeloma-associated bone disease

    Distribution of T cell subsets in human lymph nodes.

    Full text link
    corecore